NCT03570476View on ClinicalTrials.gov

Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

July 3, 2019

Conditions
Prostate Adenocarcinoma Without Neuroendocrine DifferentiationStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8
Interventions
DRUG

Olaparib

Given orally

PROCEDURE

Radical Prostatectomy

Undergo surgery

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

AstraZeneca

INDUSTRY

lead

University of Washington

OTHER